Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Meredith Clement

Concepts (204)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pre-Exposure Prophylaxis
21
2026
272
8.560
Why?
HIV Infections
37
2026
3215
5.330
Why?
Anti-HIV Agents
17
2026
914
3.760
Why?
Syphilis
6
2017
39
2.630
Why?
Sexually Transmitted Diseases
4
2023
163
2.480
Why?
Sexual and Gender Minorities
6
2025
269
2.220
Why?
Homosexuality, Male
9
2025
231
1.860
Why?
Sexual Health
2
2024
67
1.350
Why?
Treponema pallidum
2
2017
11
0.960
Why?
Hepatitis C
3
2018
251
0.940
Why?
Pyridones
4
2026
210
0.930
Why?
Louisiana
5
2026
30
0.930
Why?
Penicillin G Benzathine
2
2015
3
0.870
Why?
New Orleans
4
2026
19
0.860
Why?
Obstetrics
1
2026
179
0.820
Why?
Focus Groups
2
2025
588
0.820
Why?
Gynecology
1
2026
185
0.810
Why?
Injections, Intramuscular
3
2021
140
0.730
Why?
Electronic Health Records
3
2025
1210
0.670
Why?
Acquired Immunodeficiency Syndrome
2
2023
238
0.660
Why?
HIV-1
6
2026
913
0.640
Why?
Male
40
2026
73396
0.630
Why?
Asymptomatic Infections
2
2018
40
0.600
Why?
Continuity of Patient Care
2
2019
298
0.600
Why?
Disease Eradication
1
2018
9
0.550
Why?
Syphilis Serodiagnosis
1
2017
6
0.530
Why?
Public-Private Sector Partnerships
1
2018
45
0.520
Why?
Community Networks
1
2018
60
0.510
Why?
Humans
47
2026
146342
0.490
Why?
Coinfection
1
2018
143
0.480
Why?
Education, Medical, Continuing
1
2017
130
0.480
Why?
Referral and Consultation
2
2021
881
0.480
Why?
North Carolina
4
2021
127
0.470
Why?
Anti-Bacterial Agents
3
2017
1942
0.460
Why?
Coronary Artery Bypass
1
2018
269
0.450
Why?
Internship and Residency
1
2026
1281
0.450
Why?
Hepatitis, Viral, Human
1
2015
22
0.450
Why?
HIV
3
2023
249
0.440
Why?
Universities
1
2018
451
0.440
Why?
Physicians, Primary Care
1
2017
210
0.430
Why?
Female
32
2026
79499
0.420
Why?
Adult
24
2026
41087
0.410
Why?
Acute Coronary Syndrome
1
2018
299
0.410
Why?
Public Health
1
2019
574
0.400
Why?
Antigens, Bacterial
1
2014
125
0.400
Why?
Cardiac Catheterization
1
2018
571
0.400
Why?
Sexual Behavior
3
2022
490
0.380
Why?
Algorithms
2
2018
1849
0.370
Why?
Percutaneous Coronary Intervention
1
2018
550
0.350
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2016
449
0.350
Why?
RNA, Viral
3
2026
693
0.330
Why?
Practice Patterns, Physicians'
2
2017
1408
0.330
Why?
Cardiovascular Diseases
3
2019
2219
0.320
Why?
Diketopiperazines
4
2026
24
0.310
Why?
Middle Aged
18
2026
36619
0.310
Why?
United States
10
2026
16136
0.300
Why?
Tenofovir
4
2024
300
0.270
Why?
Veterans
2
2017
1650
0.270
Why?
Health Services Accessibility
3
2026
1107
0.270
Why?
Medication Adherence
3
2021
535
0.250
Why?
Primary Health Care
1
2017
1776
0.240
Why?
Antibodies, Monoclonal, Humanized
2
2024
992
0.240
Why?
Transgender Persons
3
2024
213
0.230
Why?
Viremia
1
2026
158
0.220
Why?
CD4 Lymphocyte Count
2
2023
280
0.220
Why?
Retrospective Studies
10
2023
17438
0.200
Why?
Drug Prescriptions
2
2017
314
0.200
Why?
Quinolones
1
2026
204
0.200
Why?
Antiviral Agents
2
2021
779
0.200
Why?
Heart Ventricles
2
2019
762
0.200
Why?
Sensitivity and Specificity
3
2018
1998
0.190
Why?
Health Knowledge, Attitudes, Practice
2
2024
1408
0.180
Why?
Health Personnel
2
2026
754
0.180
Why?
Hydroxychloroquine
1
2022
65
0.180
Why?
Trust
1
2024
160
0.180
Why?
Qualitative Research
2
2026
1734
0.170
Why?
Interviews as Topic
1
2025
930
0.170
Why?
Sex Work
1
2021
23
0.170
Why?
Aged
10
2024
26432
0.160
Why?
Cohort Studies
4
2026
6077
0.160
Why?
Incidence
3
2024
2936
0.160
Why?
Information Seeking Behavior
1
2021
39
0.160
Why?
HIV Integrase Inhibitors
1
2021
80
0.160
Why?
Condoms
1
2021
99
0.160
Why?
Interleukin-6
1
2024
784
0.150
Why?
Clinical Alarms
1
2019
11
0.140
Why?
Clinical Deterioration
1
2019
10
0.140
Why?
Mass Screening
2
2017
1307
0.140
Why?
Patient Acuity
1
2019
46
0.140
Why?
Echocardiography
2
2019
645
0.140
Why?
Antibodies, Neutralizing
1
2021
348
0.140
Why?
Drug Interactions
1
2020
405
0.140
Why?
Macrophages
1
2026
1532
0.130
Why?
Double-Blind Method
4
2024
2070
0.130
Why?
Emtricitabine
3
2024
209
0.130
Why?
Myocardial Contraction
1
2019
292
0.130
Why?
Likelihood Functions
1
2018
138
0.130
Why?
Valine
1
2018
84
0.130
Why?
Hypertrophy, Left Ventricular
1
2018
124
0.130
Why?
Chemoprevention
1
2018
91
0.130
Why?
Immunity, Cellular
1
2019
277
0.130
Why?
Immunoenzyme Techniques
1
2017
197
0.130
Why?
Disease Transmission, Infectious
1
2018
69
0.130
Why?
Glutamine
1
2018
110
0.130
Why?
Carnitine
1
2018
91
0.130
Why?
Pharmacogenetics
1
2018
176
0.120
Why?
Antibodies, Bacterial
1
2017
147
0.120
Why?
Machine Learning
1
2023
594
0.120
Why?
Patient Acceptance of Health Care
1
2024
881
0.120
Why?
Hepacivirus
1
2018
237
0.120
Why?
Hepatitis C, Chronic
1
2018
150
0.120
Why?
Stroke Volume
1
2019
652
0.120
Why?
Acetamides
2
2026
42
0.110
Why?
Ambulatory Care Facilities
1
2018
269
0.110
Why?
Brain Death
1
2015
59
0.110
Why?
Indazoles
2
2026
86
0.110
Why?
Health Services Needs and Demand
1
2017
287
0.110
Why?
Reagins
1
2014
2
0.110
Why?
Dysuria
1
2014
3
0.110
Why?
Ventricular Dysfunction, Left
1
2018
391
0.110
Why?
Serologic Tests
1
2014
50
0.110
Why?
Exanthema
1
2015
86
0.110
Why?
American Heart Association
1
2016
364
0.100
Why?
Metabolome
1
2018
390
0.100
Why?
Immunoassay
1
2014
108
0.100
Why?
Cholesterol
1
2016
411
0.100
Why?
Fever
1
2015
322
0.100
Why?
Patient Selection
1
2018
728
0.100
Why?
Risk
1
2016
920
0.100
Why?
Immunoglobulin G
1
2017
901
0.100
Why?
Pandemics
1
2022
1707
0.100
Why?
Intention to Treat Analysis
2
2024
78
0.100
Why?
Health Policy
1
2015
399
0.090
Why?
Aspirin
1
2015
405
0.090
Why?
Pregnancy
2
2015
7230
0.090
Why?
Societies, Medical
1
2016
907
0.090
Why?
United States Department of Veterans Affairs
1
2016
777
0.080
Why?
Pneumonia
1
2017
635
0.080
Why?
Proteomics
1
2018
1203
0.080
Why?
Drug Administration Schedule
2
2024
790
0.080
Why?
Administration, Oral
2
2024
872
0.080
Why?
Coronary Artery Disease
1
2015
751
0.070
Why?
Clinical Competence
1
2017
1272
0.070
Why?
Decision Making
1
2015
993
0.070
Why?
Practice Guidelines as Topic
1
2016
1591
0.070
Why?
Hospitalization
1
2018
2475
0.060
Why?
Mississippi
1
2026
34
0.060
Why?
Alabama
1
2026
42
0.060
Why?
Risk Factors
2
2018
10921
0.060
Why?
Spain
1
2026
50
0.060
Why?
Drug Resistance, Viral
1
2026
127
0.060
Why?
Injection Site Reaction
1
2024
4
0.050
Why?
Europe
1
2026
421
0.050
Why?
Severity of Illness Index
2
2024
2921
0.050
Why?
Surveys and Questionnaires
1
2017
6073
0.050
Why?
Injections, Subcutaneous
1
2024
170
0.050
Why?
Social Stigma
1
2026
174
0.050
Why?
Treatment Outcome
3
2024
11821
0.050
Why?
Drug Combinations
1
2024
400
0.050
Why?
Virus Replication
1
2026
526
0.050
Why?
Chloroquine
1
2022
54
0.050
Why?
Drugs, Generic
1
2022
28
0.040
Why?
Prevalence
2
2019
2861
0.040
Why?
Young Adult
3
2024
14330
0.040
Why?
Assisted Living Facilities
1
2021
20
0.040
Why?
Immunization, Passive
1
2021
90
0.040
Why?
Drug Resistance
1
2021
145
0.040
Why?
Drug Approval
1
2021
94
0.040
Why?
Delayed-Action Preparations
1
2021
192
0.040
Why?
Infusions, Intravenous
1
2021
432
0.040
Why?
CD4-Positive T-Lymphocytes
1
2026
1150
0.040
Why?
Adolescent
3
2024
22557
0.040
Why?
Skilled Nursing Facilities
1
2021
152
0.040
Why?
Follow-Up Studies
2
2019
5439
0.040
Why?
Healthcare Disparities
1
2026
733
0.040
Why?
Cost-Benefit Analysis
1
2022
640
0.040
Why?
Hospitals, Community
1
2019
68
0.030
Why?
Ribavirin
1
2018
81
0.030
Why?
Diastole
1
2018
147
0.030
Why?
Early Diagnosis
1
2019
251
0.030
Why?
Interferons
1
2018
186
0.030
Why?
Antibodies, Monoclonal
1
2024
1512
0.030
Why?
Interleukins
1
2018
248
0.030
Why?
Biomarkers
2
2018
4340
0.030
Why?
Nursing Staff, Hospital
1
2019
146
0.030
Why?
Africa South of the Sahara
1
2015
56
0.030
Why?
Ventricular Function, Left
1
2019
541
0.030
Why?
Polymorphism, Genetic
1
2018
612
0.030
Why?
Patient Transfer
1
2019
224
0.030
Why?
Academic Medical Centers
1
2019
561
0.030
Why?
Kenya
1
2015
129
0.030
Why?
Prospective Studies
1
2026
8123
0.030
Why?
Hospital Mortality
1
2019
1051
0.020
Why?
Risk Reduction Behavior
1
2015
220
0.020
Why?
Guidelines as Topic
1
2015
267
0.020
Why?
Genotype
1
2018
1879
0.020
Why?
Comorbidity
1
2018
1665
0.020
Why?
Odds Ratio
1
2015
1077
0.020
Why?
Intensive Care Units
1
2019
925
0.020
Why?
Attitude of Health Personnel
1
2019
1219
0.020
Why?
Phenotype
1
2018
3206
0.020
Why?
Aged, 80 and over
1
2021
8391
0.020
Why?
Case-Control Studies
1
2015
3647
0.020
Why?
Child
1
2022
22693
0.010
Why?
Clement's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)